Cited by 598Thyroid Disorders and TreatmentsDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index; none of the 4 sources its claims cite is checked for support yet.

Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders

Open access

Abstract

Thyroid dysfunction and diabetes mellitus are closely linked. Several studies have documented the increased prevalence of thyroid disorders in patients with diabetes mellitus and vice versa. This review critically discusses the different underlying mechanisms linking type 1 and 2 diabetes and thyroid dysfunction to demonstrate that the association of these two common disorders is unlikely a simple coincidence. We assess the current state of knowledge on the central and peripheral control of thyroid hormone on food intake and glucose and lipid metabolism in target tissues (such as liver, white and brown adipose tissue, pancreatic β cells, and skeletal muscle) to explain the mechanism linking overt and subclinical hypothyroidism to type 2 diabetes and metabolic syndrome. We also elucidate the common susceptibility genes and the pathogenetic mechanisms contributing to the autoimmune mechanism involved in the onset of type 1 diabetes mellitus and autoimmune thyroid disorders. An untreated thyroid dysfunction can impair the metabolic control of diabetic patients, and this association can have important repercussions on the outcome of both of these disorders. Therefore, we offer recommendations for the diagnosis, management, and screening of thyroid disorders in patients with diabetes mellitus, including the treatment of diabetic patients planning a pregnancy. We also discuss the major causes of failure to achieve an optimal management of thyroid dysfunction in diabetic patients and provide recommendations for assessing and treating these disorders during therapy with antidiabetic drugs. An algorithm for a correct approach of these disorders when linked is also provided.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that thyroid dysfunction (TD) and diabetes mellitus (DM) are closely associated through shared autoimmunity, thyroid hormone effects on glucose/lipid metabolism, and drug interactions. It summarizes prevalence, mechanisms, prognosis, and management/screening recommendations, emphasizing that untreated TD can impair metabolic control in patients with diabetes.

Key findings

  • Autoimmune thyroid disease occurs in 17% to 30% of adults with type 1 diabetes (T1D), and autoimmune hypothyroidism is present in 25% of children with T1D.
  • TD is more common in type 2 diabetes (T2D) than in the general population; hypothyroidism prevalence in T2D ranges from 6% to 20%, and a meta-analysis found a 1.93-fold higher pooled prevalence of subclinical hypothyroidism in T2D versus healthy controls (95% CI, 1.66 to 2.24).
  • Subclinical hypothyroidism in T2D was associated with increased risks of diabetic nephropathy (OR 1.74; 95% CI, 1.34 to 2.28), diabetic retinopathy (OR 1.42; 95% CI, 1.21 to 1.67), peripheral arterial disease (OR 1.85; 95% CI, 1.35 to 2.54), and diabetic peripheral neuropathy (OR 1.87; 95% CI, 1.06 to 3.28), but not coronary heart disease.
  • Hyperthyroidism is found in 4.4% of adults with T2D, and subclinical hyperthyroidism in ~2% to 4%; preexisting DM is exacerbated by hyperthyroidism, and insulin treatment should be adjusted after TD occurs. Metformin lowers TSH in overt and subclinical hypothyroidism but not in euthyroid patients, with a TSH cut-off of 2.5 to 3 mU/L predicting the effect.

Methods

  • Narrative review based on personal files, MEDLINE articles, meta-analyses, references of relevant articles and textbooks published from 1977 to 2018, and recent international guidelines.
  • Search terms included thyroxine, triiodothyronine, hypothyroidism, hyperthyroidism, subclinical thyroid disease, type 1 and type 2 diabetes mellitus, insulin resistance, metabolic syndrome, gestational diabetes, prevalence, incidence, deiodinases, glucose metabolism, lipid metabolism, adipose tissue, appetite regulation, skeletal muscle, screening, morbidity, and mortality.
  • The authors performed a critical assessment of the literature, agreed on inclusion/exclusion criteria, preferred high-quality papers, meta-analyses, randomized controlled and longitudinal trials, and discussed limitations in study design or execution when identified.

Limitations

  • The paper states that limitations in study design or execution were discussed when identified, but it is a narrative review without new primary data and relies heavily on observational studies, meta-analyses, and guideline documents.
  • The authors note insufficient evidence to determine specific screening tests, exact screening intervals, and cost-benefit for TD screening in T2D; they also note no prospective randomized controlled trial evaluating whether treating subclinical hyperthyroidism improves adverse outcomes.
  • The text reports heterogeneity among included studies in meta-analyses of subclinical hypothyroidism and metabolic syndrome, conflicting results from Danish register-based studies on TD and diabetes incidence, and inconsistent findings on the D2 Thr92Ala polymorphism and insulin resistance/T2D.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/er.2018-00163

Cites

410 of 410 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 4 cited sources checked · 0 supported · 0 flagged

Show all 81 claims

  • It may state two separate claims as one. 46
  • Probably not a substantial claim. 6
50 of 50
  • The paper relies on this without support.

    Insulin resistance is the main clinical and pathogenic feature of metabolic syndrome.

    “Isulin resistance is the main clinical and pathogenic feature of this syndrome.”
  • The paper relies on this without support.

    Human brown adipose tissue is more important in neonates than in adults.

    “However, human BAT is considered more important in neonates than in the adults.”
  • The paper relies on this without support.

    The prevalence of hypothyroidism in women of reproductive age is 2% to 3%.

    “The prevalence of hypothyroidism in women during the reproductive age is % to %, and chronic autoimmune thyroiditis is the main cause of hypothyroidism during pregnancy.”
  • The paper relies on this without support.

    Postpartum thyroiditis is caused by destructive autoimmune thyroiditis in the postpartum period, mediated by a rebound of cellular and humoral immunity.

    “Postpartum thyroiditis (PPTD) is caused by a destructive autoimmune thyroiditis in the postpartum period, mediated by a rebound of both cellular and humoral immunity.”
  • The paper relies on this without support.

    The cost-benefit ratio is favorable for screening thyroid dysfunction in type 1 diabetes.

    “• The cost-benefit ratio is favorable for a screening of TD.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Items 401–410 of 410

Flagged first, then by citations

Research works printed but not linked: 4

  1. Centers for Disease Control and Prevention, 2011, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011
  2. 2003, 26, 1181
  3. 2000, J Gorgan Uni Med Sci, 2, 5
  4. Efe, 1999, Effects of second generation sulfonylureas on the thyroid, Turk J Endocrinol Metab., 4, 173

Cited by

Sorted by citations

See all 598

Metadata

Authors
Biondi, B., Kahaly, G. J., & Robertson, R. P.
Affiliations
  • Federico II University Hospital (IT)
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • University of Washington (US)
Corresponding author
Biondi, Bernadette
Venue
Endocrine Reviews
Published
2019-01-14
Volume
40
Issue
3
Pages
789-824
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2909632761
Cited by
598
References
410
Citations by year
2026: 81 · 2025: 105 · 2024: 120 · 2023: 107 · 2022: 98 · 2021: 50 · 2020: 28 · 2019: 9
FWCI
7.09
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (NIDDK RO-1 38325-35)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
thyroid dysfunction, diabetes mellitus, type 1 diabetes, type 2 diabetes, subclinical hypothyroidism, overt hypothyroidism, metabolic syndrome, thyroid hormone regulation, glucose metabolism, lipid metabolism, adipose tissue, pancreatic beta cells, skeletal muscle, autoimmune thyroid disease, susceptibility genes, antidiabetic drugs, treatment algorithm
MeSH terms
Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypothyroidism, Thyroid Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review